STOCKHOLM, May 28, 2021 /PRNewswire/ -- Calliditas
Therapeutics AB (publ) ("Calliditas") today announced that
management will present at the Jefferies Virtual Healthcare
Conference on Tuesday, June 1, 2021
at 2:30 pm CET/8:30 am ET. Calliditas will also host 1x1
meetings during the conference. Details for the presentation are as
follows:
Jefferies Virtual Healthcare Conference
Date: Tuesday, June 1, 2021
Time: 2:30 pm CET / 8:30 am ET
Registration Link:
https://wsw.com/webcast/jeff174/register.aspx?conf=jeff174&page=calt&mmid=3325730&refer=meetmax&firstname=&lastname=
The webcast will be archived for a period of 30 days following
the conclusion of the event.
For further information, please contact:
Marie Galay, IR Manager,
Calliditas
Tel.: +44 79 55 12 98 45
email: marie.galay@calliditas.com
The information was sent for publication, through the agency
of the contact persons set out above, on May
28, 2021 at 12:00 p.m.
CET.
About Calliditas
Calliditas Therapeutics is a biopharma company based in
Stockholm, Sweden focused on
identifying, developing and commercializing novel treatments in
orphan indications, with an initial focus on renal and hepatic
diseases with significant unmet medical needs. Calliditas' lead
product candidate, Nefecon, is a proprietary, novel oral
formulation of budesonide, an established, highly potent local
immunosuppressant, for the treatment of the autoimmune renal
disease IgA nephropathy, or IgAN, for which there is a high unmet
medical need and there are no approved treatments. Calliditas
successfully reported top line data of its global Phase 3 study in
IgAN in November of 2020 and, if approved, aims to commercialize
Nefecon in the United States on
its own and partner elsewhere. Calliditas is listed on Nasdaq
Stockholm (ticker: CALTX) and the Nasdaq Global Select Market
(ticker: CALT). Visit www.calliditas.com for further
information.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/calliditas-therapeutics-to-present-at-jefferies-virtual-healthcare-conference,c3356146
The following files are available for download:
https://mb.cision.com/Main/16574/3356146/1424287.pdf
|
Jefferies Conference
Press Release - En
|
View original
content:http://www.prnewswire.com/news-releases/calliditas-therapeutics-to-present-at-jefferies-virtual-healthcare-conference-301301624.html
SOURCE Calliditas Therapeutics